PATHOLOGY, vol.34, no.3, pp.233-238, 2002 (SCI-Expanded)
Aims: E-cadherin has been studied recently as a potential marker for tumour progression. The present study aimed to assess the expression of E-cadherin in formalin-fixed and paraffin-embedded radical prostatectomy specimens and to compare its expression with the pathological stage and Gleason score.